/SDZNY

SDZNY Stock - Sandoz Group AG

Q: What is the analyst price target for SDZNY?

Analyst price target information is not currently available for SDZNY.

Q: What is SDZNY's market cap?

Market capitalization information is not currently available for SDZNY.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$73.81-1.87%

$1.41 (-1.87%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $81.19

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SDZNY

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.24

52W High$76.84

52W Low$35.61

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$10.38B	$9.98B	$8.60B	$8.79B	$9.04B
Gross Profit	$4.93B	$4.56B	$4.05B	$4.15B	$4.16B
Gross Margin	47.4%	45.7%	47.0%	47.2%	46.0%
Operating Income	$307.00M	$375.00M	$1.15B	$1.38B	$1.34B
Net Income	$1.00M	$77.00M	$784.05M	$830.15M	$433.64M
Net Margin	0.0%	0.8%	9.1%	9.4%	4.8%
EPS	$0.00	$0.18	$1.82	$1.93	$1.01

Company Overview

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

Visit Website

Earnings History & Surprises

SDZNY

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$0.86

Q3 2025

EPS Surprise History

Q3 25

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 3, 2026	—	—	—	—
Q3 2025	Aug 7, 2025	—	$0.86	—	—
Q1 2025	Mar 5, 2025	—	—	—	—
Q4 2024	Oct 30, 2024	—	—	—	—
Q3 2024	Aug 8, 2024	—	—	—	—

Frequently Asked Questions about SDZNY

What is SDZNY's current stock price?

Sandoz Group AG (SDZNY) is currently trading at $73.81 per share. The stock has moved -1.87% today.

What is the analyst price target for SDZNY?

No analyst price targets are currently available for this stock.

What sector is Sandoz Group AG in?

Sandoz Group AG operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is SDZNY's market cap?

Sandoz Group AG has a market capitalization of $31.79 billion, making it a large-cap company.

Does SDZNY pay dividends?

No, Sandoz Group AG does not currently pay a dividend to shareholders.